Mutual Fund Ownership
Ownership as on: Thu, 25 Apr, 2024

Kotak Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)12.36
% of AUM4.35%

DSP Midcap Fund Growth

2/5
Equity
Amount Invested (Cr.)646.18
% of AUM4.05%

LIC MF Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)2.39
% of AUM3.87%

Tata India Pharma & Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)33.63
% of AUM3.83%

ICICI Prudential Nifty Pharma Index Fund Regular Growth

NA
Index Funds
Amount Invested (Cr.)1.73
% of AUM3.80%

FAQs about Alkem Laboratories share price

Alkem Laboratories is trading at 4857.90 as on Thu Apr 25 2024 09:59:22. This is 3.10% upper as compared to its previous closing price of 4711.90.

The market capitalization of Alkem Laboratories is 58083.48 Cr as on Thu Apr 25 2024 09:59:22.

The average broker rating on Alkem Laboratories is Hold. The breakup of analyst rating is given below -

  • 2 analysts have given a strong buy rating
  • 6 analysts have given a buy rating
  • 6 analysts have given a hold rating
  • 3 analysts have given a sell rating
  • 3 analysts have given a strong sell rating

The 52 wk high for Alkem Laboratories is 5519.10 whereas the 52 wk low is 3211.05

Alkem Laboratories can be analyzed on the following key metrics -

  • TTM P/E: 39.54
  • Sector P/E: 27.41
  • Dividend Yield: 0.95%
  • D/E ratio: -

Alkem Laboratories reported a net profit of 984.17 Cr in 2023.

Recommended For You
Trending Stocks
1,127.35+63.65(5.98%)
2,562.70+59.80(2.39%)
1,643.00-200.05 (-10.85%)
2,231.00-28.15 (-1.25%)
HomeMarketsPremiumFor youGet App